Patents by Inventor David Paul Jenkins

David Paul Jenkins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9675591
    Abstract: The present invention provides methods for treating seizure disorders. The method includes administering to a subject in need thereof 2-amino-6-trifluoromethylthio-benzothiazole, or a pharmaceutically acceptable salt thereof. Methods for the treatment of pain are also described.
    Type: Grant
    Filed: April 15, 2016
    Date of Patent: June 13, 2017
    Assignee: The Regents of the University of California
    Inventors: Heike Wulff, Nichole Coleman, David Paul Jenkins
  • Publication number: 20160228416
    Abstract: The present invention provides methods for treating seizure disorders. The method includes administering to a subject in need thereof 2-amino-6-trifluoromethylthio-benzothiazole, or a pharmaceutically acceptable salt thereof. Methods for the treatment of pain are also described.
    Type: Application
    Filed: April 15, 2016
    Publication date: August 11, 2016
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Heike WULFF, Nichole COLEMAN, David Paul JENKINS
  • Patent number: 7176195
    Abstract: Compounds according to general formulae (1 and 2), wherein G1 is an azepine derivative and G2 is a group according to general formulae (9–11) are new. Compounds according to the invention are vasopressin V2 receptor agonists.
    Type: Grant
    Filed: June 21, 2001
    Date of Patent: February 13, 2007
    Assignee: Ferring BV
    Inventors: Doreen Ashworth, Gary R. W. Pitt, Peter Hudson, Christopher Yea, Richard J. Franklin, Graeme Semple, David Paul Jenkins
  • Publication number: 20040038962
    Abstract: Compounds according to general formulae (1 and 2), wherein G1 is an azepine derivative and G2 is a group according to general formulae (9-11) are new. Compounds according to the invention are vasopressin V2 receptor agonists. Pharmaceutical compositions of the compounds are useful as antidiuretic agents.
    Type: Application
    Filed: June 13, 2003
    Publication date: February 26, 2004
    Inventors: Doreen Ashworth, Gary R W Pitt, Peter Hudson, Christopher Yea, Richard J Franklin, Graeme Semple, David Paul Jenkins